MicroStrategy
MSTR
NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
ASMB Assembly Biosciences
- 15.210
- -0.600-3.80%
Close Dec 20 16:00 ET
- 15.210
- 0.0000.00%
Post 20:01 ET
96.68MMarket Cap-2.21P/E (TTM)
16.256High15.000Low30.66KVolume15.700Open15.810Pre Close478.21KTurnover0.78%Turnover RatioLossP/E (Static)6.36MShares19.93052wk High3.72P/B60.11MFloat Cap9.12152wk Low--Dividend TTM3.95MShs Float1260.000Historical High--Div YieldTTM7.94%Amplitude7.692Historical Low15.599Avg Price1Lot Size
About Assembly Biosciences Company
Assembly Biosciences, Inc. is a biotechnology company, which engages in the development of products for infectious diseases, such as chronic hepatitis B virus and illnesses associated with a dysbiotic microbiome. It focuses on two innovative platform programs: oral therapeutics for the treatment of hepatitis B virus, and the oral synthetic live biotherapeutics candidate. The company was founded by Uri Lopatin and Derek A. Small on October 7, 2005 and is headquartered in South San Francisco, CA.
Company Profile
SymbolASMB
Company NameAssembly Biosciences
Listing DateDec 17, 2010
Issue Price6.00
Founded2005
CEOMr. Jason A. Okazaki
MarketNASDAQ
Employees65
Fiscal Year Ends12-31
AddressTwo Tower Place,7th floor
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-833-509-4583
Websitehttp://www.assemblybio.com
Company Executives
- Name
- Position
- Salary
- Jason A. Okazaki
- Director, President, Chief Executive Officer and Principal Financial Officer
- 1.37M
- Anuj Gaggar
- Chief Medical Officer
- --
- Nicole S White
- Chief Manufacturing Officer
- 705.51K
- William E. Delaney, PhD
- Chief Scientific Officer
- 811.82K
- Jeanette M. Bjorkquist
- Executive Director, Accounting and Treasury and Principal Accounting Officer
- --
- William R. Ringo, Jr
- Chairman of the Board
- 122.08K
- Dr. John G. McHutchison, A.O.,M.D.
- Director
- 64.58K
- Dr. Tomas Cihlar, PhD
- Director
- --
- Robert D. Cook, II
- Director
- --
- Dr. Michael Houghton
- Independent Director
- 59.58K
- Gina Consylman
- Independent Director
- 72.08K
- Dr. Susan Mahony, M.B.A.,PhD
- Independent Director
- 74.58K
- Anthony E. Altig
- Independent Director
- 79.58K
- Dr. Lisa R. Johnson-Pratt
- Independent Director
- 64.58K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.